GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Orbital Sidekick Closes $16m Series A Financing

13 Apr 2021 07:00

RNS Number : 2180V
Allied Minds PLC
13 April 2021
 

13 April 2021

 

Allied Minds

 

Orbital Sidekick Closes $16 million Series A Financing

 

Allied Minds plc (LSE: ALM), the IP commercialisation company focused on early stage company development within the technology sector, is pleased to announce that its portfolio company, Orbital Sidekick, Inc. ("OSK") has completed the closing of its $16 million Series A funding round led by Temasek, an investment company headquartered in Singapore, with participation from Energy Innovation Capital, Syndicate 708, and existing investors Allied Minds and 11.2 Capital.

 

OSK will use proceeds from the financing to expand its innovative product updates, new strategic partnerships, and introduce its advanced monitoring technology to new industries.

 

In response to the Energy sector's demand for better leak monitoring, OSK has developed various external partnerships to execute pilot flights, most notably with global energy leader Phillips 66 (P66) and the iPIPE consortium of operators which includes premier natural gas pipeline transporters Energy Transfer and TC Energy, among others. OSK is transitioning to and expanding satellite operations within these partnerships in 2021 with a path towards full commercialisation next year. OSK is also launching its Global Hyperspectral Observation Satellite constellation, known as GHOSt, on multiple SpaceX Falcon 9 missions beginning in Q1 2022.

 

Looking to broaden its commercial capabilities beyond the energy sector, in 2021 OSK is exploring new markets to use its technology to help solve pressing global challenges. One such capability is regional fire risk detection in response to a proliferation of forest fires across the globe during the past year. The company is also employing its analytics platform for global emissions monitoring and mineral detection. OSK has doubled its team to date and will continue to hire through 2021 and into 2022 to further expand its analytics, software engineering, and product development teams. This new talent will further OSK's core capabilities while also supporting these expanded offerings.

 

 

For more information, please contact:

 

Allied Minds plc

c/o Instinctif Partners

Harry Rein

Instinctif

alliedminds@instinctif.com

Tim Linacre / Rozi Morris / Hannah Campbell

 

About Allied Minds

Allied Minds plc is an IP commercialisation company focused on early stage company development within the technology sector. With origination relationships that span US federal laboratories, universities, and leading US corporations, Allied Minds historically created, and now operates and funds, a portfolio of companies to generate long-term value for its investors and stakeholders. Based in Boston, Allied Minds supports its businesses with capital, management, expertise and shared services. For more information, please visit www.alliedminds.com.

 

About Orbital Sidekick

Orbital Sidekick's proprietary analytics platform and hyperspectral payload architecture provide persistent space-based monitoring solutions powered by Spectral IntelligenceTM. This unique radiometric speciation and change detection capability enables unparalleled target monitoring services for both commercial and defense users on a global scale. For more information on Orbital Sidekick's global persistent monitoring services, please visit www.orbitalsidekick.com.

 

Further information about the Series A financing

The transaction was completed at a pre-money valuation of $30.0 million, up from the post-money valuation of $11.7 million. Allied Minds invested an aggregate of $2.5 million in the financing (inclusive of $1.5 million through the conversion of its simple agreement for equity (SAFE)). Following the closing, Allied Minds' ownership of issued share capital is 26.52% and fully-diluted ownership is 24.11%.

 

Allied Minds Forward‐Looking Statement

This press release contains statements that are or may be forward‐looking statements, including statements that relate to Allied Minds' future prospects, developments and strategies. The forward‐looking statements are based on current expectations and are subject to known and unknown risks and uncertainties that could cause actual results, performance and achievements to differ materially from current expectations, including, but not limited to, those risks and uncertainties described in the risk factors included in Allied Minds' regulatory filings. These forward‐looking statements are based on assumptions regarding the present and future business strategies of Allied Minds and the environment in which it will operate in the future. Each forward‐looking statement speaks only as at the date of this press release. Except as required by law, regulatory requirement, the Listing Rules and the Disclosure Guidance and Transparency Rules, neither Allied Minds nor any other party intends to update or revise these forward‐looking statements, whether as a result of new information, future events or otherwise.

 

###

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAFLAFFEFEAA
Date   Source Headline
9th Feb 20164:35 pmRNSPrice Monitoring Extension
9th Feb 20167:00 amRNSTrading Statement
4th Feb 20163:15 pmRNSHolding(s) in Company
4th Feb 20167:00 amRNSAllied Minds Subsidiary Produces Prototype
1st Feb 20167:00 amRNSAllied Minds Subsidiary Raises $22 million
15th Jan 20167:00 amRNSDirectorate Change
11th Jan 20165:31 pmRNSHolding(s) in Company
7th Jan 20164:57 pmRNSBlocklisting Six Monthly Return
3rd Nov 20153:55 pmRNSTotal Voting Rights
28th Oct 201510:53 amRNSHolding(s) in Company
13th Oct 20154:53 pmRNSHolding(s) in Company
12th Oct 20152:58 pmRNSHolding(s) in Company
5th Oct 20157:00 amRNSPrecision Biopsy Raises $33.6 Million
23rd Sep 20157:00 amRNSFederated Wireless NASCTN first pilot test
17th Sep 20157:00 amRNSFormation of HawkEye 360
4th Sep 20154:19 pmRNSDirectorate Change
1st Sep 20157:03 amRNSAllied Minds Names Joseph Pignato as CFO
27th Aug 20157:04 amRNSHalf Yearly Report
27th Aug 20157:01 amRNSABLS Licenses Technology and Molecules from Yale
25th Aug 20154:24 pmRNSAppointment of New Senior Independent Director
31st Jul 20153:02 pmRNSTotal Voting Rights
30th Jun 20159:37 amRNSTotal Voting Rights
26th Jun 20155:16 pmRNSDirector/PDMR Shareholding
22nd Jun 20157:00 amRNSABLS licenses IP from Harvard
10th Jun 20155:06 pmRNSBlocklisting Six Monthly Return
5th Jun 20157:30 amRNSLong Term Incentive Plan
5th Jun 20157:00 amRNSAppointment of Kevin Sharer to Board of Directors
28th May 20156:06 pmRNSResult of AGM
28th May 20157:00 amRNSAGM Statement
22nd May 20154:07 pmRNSHolding(s) in Company
21st May 20152:17 pmRNSHolding(s) in Company
20th May 20157:33 amRNSResults of Placing
28th Apr 201512:00 pmRNSCapital Markets Day
28th Apr 20157:31 amRNSAnnual Results Release
28th Apr 20157:00 amRNSAppointment of New Non-Executive Chairman
22nd Apr 20157:00 amRNSSciFluor Life Sciences Raises $30 Million
2nd Apr 20153:40 pmRNSHolding(s) in Company
1st Apr 20154:33 pmRNSTotal Voting Rights
26th Mar 20152:30 pmRNSNotice of Results and Capital Markets Day
20th Mar 20154:35 pmRNSPrice Monitoring Extension
10th Mar 20157:02 amRNSAllied Minds Announces the Formation of BridgeSat
3rd Feb 20154:06 pmRNSHolding(s) in Company
8th Jan 20157:00 amRNSSciFluor Life Sciences Awarded U.S. Patent
4th Dec 20147:00 amRNSSciFluor Life Sciences Awarded U.S. Patent
19th Nov 201410:03 amRNSBlock Listing of Shares
12th Nov 20147:00 amRNSAllied Minds Appointment of Joint Broker
5th Nov 20147:00 amRNSAllied Minds Appoints Donna See as Vice President
30th Oct 20147:00 amRNSAllied Minds forms Seamless Devices, Inc.
20th Oct 20143:12 pmRNSHolding(s) in Company
9th Oct 201410:11 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.